Поставщики · Производитель · Редактирование генома и эпигенома (только сельское хозяйство и промышленность; CRISPR-платформы для медицины в каталог не входят)

Shandong Shunfeng Biotechnology

работает КитайАзия Основана 2018 проверено 2026-10-05

Профиль

Shandong Shunfeng Biotechnology Co., Ltd. (Shunfeng Bio) is a privately held Chinese plant biotechnology company developing gene-editing tools and precision crop breeding; founded in 2018 and headquartered in Jinan, Shandong. Its core technology is patented CRISPR gene-editing enzymes Cas-SF01 and Cas-SF02 (a “gene scissor” platform validated in 70+ labs). Key products include high-oleic (high-oleic-acid) soybean with China’s first regulator-approved plant gene-edited safety certificate (oil-oleic 80%+, up to 85%), plus gene-edited pipelines such as dwarf corn (security certificate in 2024) and other crops. In 2025–2026 it remains active: it signed a 2025-09-10 worldwide licensing agreement with KWS for global, all-crop gene-editing applications, and 2026 news reports continued scaling (e.g., 2026 planned multi-region planting) and ongoing approvals. Reported shareholders include Jinan Henghe Bio (52.7506%) and Jinan High-tech Finance (17.5835%); no stock listing/IPO was found. Funding: 2021 and 2023/2022 rounds are mentioned in profiles but amounts/valuation are inconsistent; one source cites RMB 120m in 2021. Scale details (revenue/capacity/employees) were not provided in the search results. Partners/customers mentioned include KWS, INARI, GDM, Performance Plants, and Origin Agritech (via Cas-SF01 licensing).

Sources#

Отрасль: Семена и генетика
Темы: ГМ-признаки и редактирование генома
Роль: Производитель — “…is a privately held Chinese plant biotechnology company developing gene-editing tools and precision crop breed…”

Биорешения, которые поставляет 0

Пока не указана поставщиком в решениях с доказательствами.

Что предлагают

Компания не публикует продукты и услуги — узнаем через знакомство.

Новости и статус 6

2026-05 Последний статус: Компания продолжает работать и расширяться: заключает лицензионные соглашения и выводит на рынок культуры с редактированным геномом. ↗ ↗ ↗
2025-09-10 Seeds for Farmers | High-Yield Varieties - KWS SAAT SE & Co. KGaA
Shandong Shunfeng Biotechnology Co., Ltd. (Shunfeng Bio) is presented as a leading gene-editing biotech with independently developed CRISPR enzymes (Cas-SF01 and Cas-SF02), a robust breeding platform combining gene editing with mutagenesis and traditional …
2025-12-10 舜丰生物济南成长记：技术从0到1全球领先，正改变农业育种_澎湃山东_澎湃新闻-The Paper
Shandong Shunfeng Biotechnology (舜丰生物) in Jinan has rapidly built a world-class gene-editing platform, developing flagship tools (SF01/SF02) and achieving China’s first production-use safety certificates for gene-edited crops, enabling nationwide …
2026-05-26 山东舜丰生物科技有限公司：依托济南高新区产业基地，助力种业集群发展
Shandong Shunfeng Biotechnology Co., Ltd. leverages the Jinan High-tech Zone industrial base to support and accelerate the development of a local seed industry cluster.
2026-05-26 打破国外垄断！舜丰生物实现我国基因编辑核心技术首次对外授权出口-新黄河APP
Shandong Shunfeng Biotechnology has independently developed core plant gene-editing tools, broken foreign patent monopolies, and secured China’s first safety certificates for gene-edited crops, enabling export licensing and international collaborations to …
2025-07-28 中国″基因剪刀″首入印度——舜丰生物携基因编辑底层工具落地印度-世界农化网
Shandong Shunfeng Biotechnology has partnered with India’s NSL to license its gene-editing tools (CRISPR Cas-SF01/02) for use in crops like corn, rice, and cotton, marking its first major entry into the Asian agricultural market and expanding China’s hegemony …
2025-05-13 舜丰生物牵头的山东省重点研发计划 ″作物精准高效基因编辑育种体系构建″项目通过验收-世界农化网
Shandong Shunfeng Biotechnology led a provincial R&D program project on “Precision and Efficient Genome Editing Breeding System for Crops,” which passed acceptance with excellent overall performance. The company, in collaboration with multiple institutes and …

Связи: владельцы, партнёры, аналоги

Партнёры и сделки 1

лицензия

KWS

…n 2024) and other crops. In 2025–2026 it remains active: it signed a 2025-09-10 worldwide licensing agreement with KWS for global, all-crop gene-editing applications, and 2026 news reports continued…

Реквизиты и контакты

Контакты, руководители и юридические данные доступны участникам.

Войти как участник